EP Wealth Advisors LLC Makes New $313,000 Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

EP Wealth Advisors LLC purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,219 shares of the exchange traded fund’s stock, valued at approximately $313,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Hillcrest Wealth Advisors NY LLC boosted its stake in SPDR S&P Biotech ETF by 0.6% in the 1st quarter. Hillcrest Wealth Advisors NY LLC now owns 21,368 shares of the exchange traded fund’s stock worth $1,628,000 after purchasing an additional 125 shares during the period. Legal Advantage Investments Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 0.6% during the 1st quarter. Legal Advantage Investments Inc. now owns 22,590 shares of the exchange traded fund’s stock worth $1,722,000 after acquiring an additional 130 shares in the last quarter. FAS Wealth Partners Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 7.6% during the 1st quarter. FAS Wealth Partners Inc. now owns 1,889 shares of the exchange traded fund’s stock worth $144,000 after acquiring an additional 134 shares in the last quarter. Commerce Bank raised its holdings in shares of SPDR S&P Biotech ETF by 4.4% during the 1st quarter. Commerce Bank now owns 3,594 shares of the exchange traded fund’s stock worth $274,000 after acquiring an additional 150 shares in the last quarter. Finally, Interactive Financial Advisors Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 1.8% during the 1st quarter. Interactive Financial Advisors Inc. now owns 8,628 shares of the exchange traded fund’s stock worth $658,000 after acquiring an additional 156 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $77.11 on Monday. The stock has a market capitalization of $5.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 1 year low of $72.44 and a 1 year high of $92.60. The business’s 50 day simple moving average is $80.90 and its 200-day simple moving average is $81.67.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.